LOS ANGELES CAPITAL MANAGEMENT LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1177206
LOS ANGELES, CA
Position in ARQT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$3,638,182
+$1,765,015 QoQ
Shares Held
154,422
+139.4% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
14 quarters on record
Voting authority
Sole 25.071557161544337.ToString("F0")%
Shared 0.ToString("F0")%
None 74.92844283845565.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $690,323,052 across 153 Biotechnology names. ARQT ranks #14 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
2,144,847 | $201,872,999 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,102,634 | $133,071,972 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,880 | $60,945,843 | |
| 4 | RPRX |
Royalty Pharma plc
|
971,927 | $46,623,338 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
689,915 | $44,589,206 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
2,289,602 | $40,938,083 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,278 | $29,208,541 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
64,937 | $28,996,967 |
All Filings in ARQT
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,638,182 | 154,422 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,873,167 | 64,503 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,188,021 | 63,025 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $432,699 | 30,863 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $482,697 | 30,863 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $428,946 | 30,793 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,163,457 | 125,103 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,264,316 | 135,948 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,470,971 | 148,433 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $628,109 | 194,461 | Shares | Sole | 2024-02-06 | |
| 2022-03-31 | $505,709 | 26,257 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $580,242 | 27,977 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $668,203 | 27,970 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $728,370 | 26,690 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||